SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-048113
Filing Date
2022-08-15
Accepted
2022-08-15 17:08:06
Documents
91
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0622_abvcbio.htm   iXBRL 10-Q 1357089
2 CERTIFICATION f10q0622ex31-1_abvcbio.htm EX-31.1 11363
3 CERTIFICATION f10q0622ex31-2_abvcbio.htm EX-31.2 11000
4 CERTIFICATION f10q0622ex32-1_abvcbio.htm EX-32.1 4342
5 CERTIFICATION f10q0622ex32-2_abvcbio.htm EX-32.2 4403
  Complete submission text file 0001213900-22-048113.txt   7864225

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE abvc-20220630.xsd EX-101.SCH 106992
7 XBRL CALCULATION FILE abvc-20220630_cal.xml EX-101.CAL 38040
8 XBRL DEFINITION FILE abvc-20220630_def.xml EX-101.DEF 372738
9 XBRL LABEL FILE abvc-20220630_lab.xml EX-101.LAB 732795
10 XBRL PRESENTATION FILE abvc-20220630_pre.xml EX-101.PRE 388969
85 EXTRACTED XBRL INSTANCE DOCUMENT f10q0622_abvcbio_htm.xml XML 937463
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40700 | Film No.: 221166603
SIC: 2834 Pharmaceutical Preparations